Clinical Trial: Safety and Efficacy of MBF-118 in Patients with Crohn Disease
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Crohn Disease
Study Type: INTERVENTIONAL
Official Title: A Phase IIa, Open Label, Single-centre Study to Assess the Initial Antifibrotic Efficacy, Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Profile of MBF-118 in Crohn's Disease Patients
Brief Summary:
This is a Phase IIa (proof of concept), single center clinical trial to evaluate the safety and efficacy of daily MBF-118 oral treatment during 28 days in Crohn's disease patients on top of standard of care.
Read more